eHealth Beheer
Beheer criteriumcontroles 2/4
De CEO eHealth is Derrick Duke, benoemd in Sep2025, heeft een ambtstermijn van minder dan een jaar. De totale jaarlijkse vergoeding van { bedraagt $ 3.26M, bestaande uit 8.9% salaris en 91.1% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 1.57% van de aandelen van het bedrijf, ter waarde $ 995.46K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.3 jaar en 4.9 jaar.
Belangrijke informatie
Derrick Duke
Algemeen directeur
US$3.3m
Totale compensatie
| Percentage CEO-salaris | 8.91% |
| Dienstverband CEO | less than a year |
| Eigendom CEO | 1.6% |
| Management gemiddelde ambtstermijn | 3.3yrs |
| Gemiddelde ambtstermijn bestuur | 4.9yrs |
Recente managementupdates
Recent updates
EHTH: Margin Discipline And New Offerings Will Reframe Long Term Prospects
Analysts have cut their price targets on eHealth significantly, with the consensus fair value moving from about $12.00 to roughly $3.00 as softer 2026 revenue guidance, reduced marketing spend from a major Medicare Advantage payor, and a tougher customer acquisition backdrop weigh on expectations. Analyst Commentary Recent Street research points to a more cautious stance on eHealth, with several firms cutting price targets and resetting expectations after the 2026 revenue guide.
EHTH: Conservative 2026 Guide And Marketing Pullback Will Support Margin Repair
Analysts have cut the average price target on eHealth to about $2 to $3 per share, down sharply from prior targets near $8 to $9. They cite softer 2026 revenue guidance tied to reduced marketing spend by a key Medicare Advantage payor, conservative assumptions for the next annual enrollment period, and a planned pullback in some customer acquisition channels.EHTH: Conservative 2026 Revenue Guide Will Support Margin Focused Turnaround
Analysts have cut the average price target for eHealth by $1.50, citing softer than expected 2026 revenue guidance, reduced marketing spend by a major Medicare Advantage payor, and company plans to scale back certain customer acquisition channels while carriers remain focused on margins. Analyst Commentary Recent Street research reflects a more cautious stance on eHealth, with several firms cutting price targets and resetting expectations following the 2026 revenue guidance.EHTH: Higher 2025 Earnings Guidance Will Support Margin Focused Turnaround
Analysts have sharply cut their average price target on eHealth from about $8.50 to roughly $3.75, reflecting lower $2 targets and a focus on weaker revenue expectations, along with an increased emphasis on margins and reduced customer acquisition spending. Analyst Commentary Recent research notes on eHealth highlight a meaningful reset in expectations, with price targets clustered around $2 and ratings largely at Hold.EHTH: Higher 2025 Earnings Guidance Will Support Future Performance
Analysts have modestly adjusted their price target on eHealth to reflect a slightly higher discount rate and a small change in the assumed future P/E multiple, while keeping fair value steady at $8.50 as they reassess risk and valuation inputs without new Street research catalysts. What's in the News eHealth updated its earnings guidance for the year ending December 31, 2025, with total revenue now expected in a range of $540.0 million to $560.0 million, compared with the prior range of $525.0 million to $565.0 million (Key Developments).Market Cool On eHealth, Inc.'s (NASDAQ:EHTH) Revenues Pushing Shares 48% Lower
Feb 10
EHTH: Enrollment Strength And Softer Competition Will Support Future Performance
Analysts have trimmed their price target on eHealth to US$9 from US$10, citing price adjustments even as the annual enrollment period tracks in line with expectations, supported by solid consumer demand and early signs of a more favorable competitive backdrop. Analyst Commentary Bullish Takeaways Bullish analysts point to the annual enrollment period tracking in line with internal expectations, which they see as a sign that execution is holding up against current industry conditions.EHTH: Solid Enrollment Trends And Easing Competition Will Support Future Margins
Analysts have trimmed their price target on eHealth to US$9 from US$10, citing annual enrollment trends that are tracking in line with expectations, along with signs of steady consumer demand and a somewhat more favorable competitive backdrop. Analyst Commentary Recent commentary around the price target cut frames eHealth as a company where execution looks generally on track, but with a valuation reset to reflect a more balanced risk and reward profile.EHTH: Solid Enrollment Trends And Healthier Competition Will Support Margin Expansion
Analysts trimmed their price target on eHealth to US$9 from US$10, citing annual enrollment trends that are tracking in line with expectations, solid consumer demand on the platform, and early indications of a more favorable competitive environment. Analyst Commentary Analysts see a mixed picture for eHealth at the current US$9 price target, with solid execution on core drivers balanced against questions on how much upside is justified in the near term.EHTH: Strengthening Enrollment Trends Will Support Future Margin Expansion Potential
Analysts have trimmed their price target on eHealth from $10.00 to $9.00 per share, citing in-line annual enrollment trends supported by strong platform demand and early signs of a more favorable competitive environment. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the annual enrollment period is progressing in line with internal expectations, reinforcing confidence in management’s guidance and execution.Further Upside For eHealth, Inc. (NASDAQ:EHTH) Shares Could Introduce Price Risks After 35% Bounce
Dec 19EHTH: Improving Enrollment Dynamics Will Support Future Upside Potential
Analysts have trimmed their price target on eHealth to $9 from $10, citing an annual enrollment period that is tracking in line with expectations, supported by solid consumer demand and a gradually improving competitive landscape. Analyst Commentary Analysts view the latest price target revision as a reflection of balanced expectations for eHealth, incorporating both the progress made in the current enrollment cycle and the lingering execution and competitive risks that could affect future growth and valuation.EHTH: Future Enrollment Trends Will Support Further Upside Potential
Narrative Update on eHealth: Analyst Price Target Revised Analysts have slightly reduced their price target for eHealth, lowering it from $8.75 to $8.50. This revision is due to a modest decrease in revenue growth outlook and a marginally higher discount rate.EHTH: Future Profit Margins Will Drive Upside Despite Consumer Confusion
Analysts have revised their price target for eHealth down from $9.25 to $8.75. They cite a significant reduction in projected profit margin, even though revenue growth forecasts have slightly improved and the estimated future price-to-earnings ratio is notably higher.eHealth: Undervalued And Gaining Momentum After Q3 Earnings Beat
Nov 08eHealth, Inc. (NASDAQ:EHTH) Held Back By Insufficient Growth Even After Shares Climb 34%
Oct 28eHealth, Inc. (NASDAQ:EHTH) Surges 26% Yet Its Low P/S Is No Reason For Excitement
Sep 03The eHealth, Inc. (NASDAQ:EHTH) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
Aug 09eHealth, Inc.'s (NASDAQ:EHTH) 26% Dip In Price Shows Sentiment Is Matching Revenues
May 15
Medicare Focus And AI Projects Will Improve Operations
Revenue and earnings growth driven by increased Medicare submissions, marketing investments, and enhanced enrollment margins.Benign Growth For eHealth, Inc. (NASDAQ:EHTH) Underpins Stock's 30% Plummet
Mar 16eHealth: Another Big Run, Lock In, And Run House Money
Feb 26Market Might Still Lack Some Conviction On eHealth, Inc. (NASDAQ:EHTH) Even After 66% Share Price Boost
Dec 23Bull Run For EHealth, Inc.: Stock Flying On Solid Enrollment
Dec 17A Piece Of The Puzzle Missing From eHealth, Inc.'s (NASDAQ:EHTH) 31% Share Price Climb
Nov 08Positive Sentiment Still Eludes eHealth, Inc. (NASDAQ:EHTH) Following 25% Share Price Slump
Aug 30We Think Some Shareholders May Hesitate To Increase eHealth, Inc.'s (NASDAQ:EHTH) CEO Compensation
Jun 06Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Dec 31 2025 | US$3m | US$291k | -US$10m |
Compensatie versus markt: De totale vergoeding ($USD 3.26M ) Derrick } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 623.53K ).
Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van Derrick te vergelijken met de prestaties van het bedrijf.
CEO
Derrick Duke (58 yo)
less than a year
Tenure
US$3,262,665
Compensatie
Mr. Derrick Anthony Duke, C.F.A., serves as Chief Executive Officer and Director of eHealth, Inc. since September 18, 2025. He was President & Director of Magellan Behavioral Health of New Jersey, LLC from...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Director | less than a year | US$3.26m | 1.57% $ 995.5k | |
| Senior VP & CFO | 1.8yrs | US$1.23m | 0.89% $ 561.5k | |
| Senior VP & Chief Revenue Officer | 2.3yrs | US$1.92m | 0.44% $ 277.8k | |
| Senior Vice President of Investor Relations & Corporate Development | 18.3yrs | geen gegevens | geen gegevens | |
| Senior VP | 3.9yrs | US$1.42m | 0.46% $ 291.4k | |
| Senior VP & Chief Communications Officer | 3.3yrs | geen gegevens | geen gegevens | |
| Senior VP and Chief Sales & Carrier Officer | 2.3yrs | geen gegevens | geen gegevens | |
| Senior VP & Chief Human Resources Officer | 3.6yrs | geen gegevens | geen gegevens | |
| Senior VP | 3.3yrs | geen gegevens | geen gegevens | |
| Senior Investor Relations Manager | no data | geen gegevens | geen gegevens |
3.3yrs
Gemiddelde duur
54yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van EHTH wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.3 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Director | less than a year | US$3.26m | 1.57% $ 995.5k | |
| Independent Director | 6.8yrs | US$264.76k | 0.49% $ 309.0k | |
| Director | 4.5yrs | US$3.43m | 2.24% $ 1.4m | |
| Independent Director | 4.8yrs | US$251.64k | 0.26% $ 164.1k | |
| Independent Chair of the Board | 6.8yrs | US$340.02k | 0.32% $ 200.4k | |
| Independent Director | less than a year | geen gegevens | geen gegevens | |
| Independent Director | 5.2yrs | US$241.01k | 0.20% $ 128.3k | |
| Independent Director | 7.4yrs | US$241.64k | 0.19% $ 118.0k | |
| Independent Director | 5yrs | US$231.64k | 0.24% $ 154.3k | |
| Independent Director | 1.7yrs | US$242.87k | geen gegevens |
4.9yrs
Gemiddelde duur
58.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van EHTH wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.9 jaar).
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/03 01:12 |
| Aandelenkoers aan het einde van de dag | 2026/05/01 00:00 |
| Inkomsten | 2025/12/31 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
eHealth, Inc. wordt gevolgd door 25 analisten. 5 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Steven Valiquette | Barclays |
| Steven Valiquette | Barclays |
| Nathaniel Schindler | BofA Global Research |